| Sheila Soares, NP-C | |
|
17240 Cortez Blvd, Brooksville, FL 34601-8921 | |
| (352) 796-5111 | |
| Not Available |
| Full Name | Sheila Soares |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 17240 Cortez Blvd, Brooksville, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629666458 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | APRN11010118 (Florida) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | APRN11010118 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayfront Health Brooksville | Brooksville, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allied Healthcare Llc | 1052776366 | 14 |
| Allied Health Florida Inc | 6507212867 | 3 |
News Archive
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and Tarrot Laboratories, a business unit of Cedars-Sinai Medical Center, today announced the execution of an exclusive research collaboration and license agreement. The collaboration will focus on identifying genetic or serologic markers associated with clinical responses to anti-TNF therapies such as Cimzia, Humira and Remicade utilized in the treatment of Crohn's Disease, and the subsequent development of diagnostic tests.
Government health experts recommended Friday that all children be tested for high cholesterol before they reach puberty, in an effort to get an early start in preventing cardiovascular disease. The National Heart, Lung and Blood Institute said a child's first cholesterol check should occur between ages 9 and 11 and the test should be repeated between ages 17 and 21. The American Academy of Pediatrics endorsed the guideline.
Results from a US study suggest there is dysfunction in the neural networks responsible for emotion regulation among patients with bipolar I disorder, even during periods of euthymia.
Safeguard Scientifics, Inc. (NYSE:SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that its annual meeting of shareholders, to be held on Friday, August 28, 2009 at 8 a.m. EDT at Dolce Valley Forge, King of Prussia, PA, will be webcast live and available via toll-free conference call.
› Verified 1 days ago
| Entity Name | Cogent Healthcare Of Pensacola Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346287182 PECOS PAC ID: 1153226766 Enrollment ID: O20031205000170 |
News Archive
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and Tarrot Laboratories, a business unit of Cedars-Sinai Medical Center, today announced the execution of an exclusive research collaboration and license agreement. The collaboration will focus on identifying genetic or serologic markers associated with clinical responses to anti-TNF therapies such as Cimzia, Humira and Remicade utilized in the treatment of Crohn's Disease, and the subsequent development of diagnostic tests.
Government health experts recommended Friday that all children be tested for high cholesterol before they reach puberty, in an effort to get an early start in preventing cardiovascular disease. The National Heart, Lung and Blood Institute said a child's first cholesterol check should occur between ages 9 and 11 and the test should be repeated between ages 17 and 21. The American Academy of Pediatrics endorsed the guideline.
Results from a US study suggest there is dysfunction in the neural networks responsible for emotion regulation among patients with bipolar I disorder, even during periods of euthymia.
Safeguard Scientifics, Inc. (NYSE:SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that its annual meeting of shareholders, to be held on Friday, August 28, 2009 at 8 a.m. EDT at Dolce Valley Forge, King of Prussia, PA, will be webcast live and available via toll-free conference call.
› Verified 1 days ago
| Entity Name | Central Florida Inpatient Medicine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649228859 PECOS PAC ID: 7911805254 Enrollment ID: O20031223000824 |
News Archive
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and Tarrot Laboratories, a business unit of Cedars-Sinai Medical Center, today announced the execution of an exclusive research collaboration and license agreement. The collaboration will focus on identifying genetic or serologic markers associated with clinical responses to anti-TNF therapies such as Cimzia, Humira and Remicade utilized in the treatment of Crohn's Disease, and the subsequent development of diagnostic tests.
Government health experts recommended Friday that all children be tested for high cholesterol before they reach puberty, in an effort to get an early start in preventing cardiovascular disease. The National Heart, Lung and Blood Institute said a child's first cholesterol check should occur between ages 9 and 11 and the test should be repeated between ages 17 and 21. The American Academy of Pediatrics endorsed the guideline.
Results from a US study suggest there is dysfunction in the neural networks responsible for emotion regulation among patients with bipolar I disorder, even during periods of euthymia.
Safeguard Scientifics, Inc. (NYSE:SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that its annual meeting of shareholders, to be held on Friday, August 28, 2009 at 8 a.m. EDT at Dolce Valley Forge, King of Prussia, PA, will be webcast live and available via toll-free conference call.
› Verified 1 days ago
| Entity Name | Value Based Inpatient Specialist |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790260388 PECOS PAC ID: 9436589553 Enrollment ID: O20200413003448 |
News Archive
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and Tarrot Laboratories, a business unit of Cedars-Sinai Medical Center, today announced the execution of an exclusive research collaboration and license agreement. The collaboration will focus on identifying genetic or serologic markers associated with clinical responses to anti-TNF therapies such as Cimzia, Humira and Remicade utilized in the treatment of Crohn's Disease, and the subsequent development of diagnostic tests.
Government health experts recommended Friday that all children be tested for high cholesterol before they reach puberty, in an effort to get an early start in preventing cardiovascular disease. The National Heart, Lung and Blood Institute said a child's first cholesterol check should occur between ages 9 and 11 and the test should be repeated between ages 17 and 21. The American Academy of Pediatrics endorsed the guideline.
Results from a US study suggest there is dysfunction in the neural networks responsible for emotion regulation among patients with bipolar I disorder, even during periods of euthymia.
Safeguard Scientifics, Inc. (NYSE:SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that its annual meeting of shareholders, to be held on Friday, August 28, 2009 at 8 a.m. EDT at Dolce Valley Forge, King of Prussia, PA, will be webcast live and available via toll-free conference call.
› Verified 1 days ago
| Entity Name | Allied Healthcare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558089367 PECOS PAC ID: 1052776366 Enrollment ID: O20230420000387 |
News Archive
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and Tarrot Laboratories, a business unit of Cedars-Sinai Medical Center, today announced the execution of an exclusive research collaboration and license agreement. The collaboration will focus on identifying genetic or serologic markers associated with clinical responses to anti-TNF therapies such as Cimzia, Humira and Remicade utilized in the treatment of Crohn's Disease, and the subsequent development of diagnostic tests.
Government health experts recommended Friday that all children be tested for high cholesterol before they reach puberty, in an effort to get an early start in preventing cardiovascular disease. The National Heart, Lung and Blood Institute said a child's first cholesterol check should occur between ages 9 and 11 and the test should be repeated between ages 17 and 21. The American Academy of Pediatrics endorsed the guideline.
Results from a US study suggest there is dysfunction in the neural networks responsible for emotion regulation among patients with bipolar I disorder, even during periods of euthymia.
Safeguard Scientifics, Inc. (NYSE:SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that its annual meeting of shareholders, to be held on Friday, August 28, 2009 at 8 a.m. EDT at Dolce Valley Forge, King of Prussia, PA, will be webcast live and available via toll-free conference call.
› Verified 1 days ago
| Entity Name | Allied Health Florida Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073225074 PECOS PAC ID: 6507212867 Enrollment ID: O20231024001221 |
News Archive
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and Tarrot Laboratories, a business unit of Cedars-Sinai Medical Center, today announced the execution of an exclusive research collaboration and license agreement. The collaboration will focus on identifying genetic or serologic markers associated with clinical responses to anti-TNF therapies such as Cimzia, Humira and Remicade utilized in the treatment of Crohn's Disease, and the subsequent development of diagnostic tests.
Government health experts recommended Friday that all children be tested for high cholesterol before they reach puberty, in an effort to get an early start in preventing cardiovascular disease. The National Heart, Lung and Blood Institute said a child's first cholesterol check should occur between ages 9 and 11 and the test should be repeated between ages 17 and 21. The American Academy of Pediatrics endorsed the guideline.
Results from a US study suggest there is dysfunction in the neural networks responsible for emotion regulation among patients with bipolar I disorder, even during periods of euthymia.
Safeguard Scientifics, Inc. (NYSE:SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that its annual meeting of shareholders, to be held on Friday, August 28, 2009 at 8 a.m. EDT at Dolce Valley Forge, King of Prussia, PA, will be webcast live and available via toll-free conference call.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sheila Soares, NP-C 11374 Chalk Farm Rd, Spring Hill, FL 34609-9637 Ph: (818) 298-2452 | Sheila Soares, NP-C 17240 Cortez Blvd, Brooksville, FL 34601-8921 Ph: (352) 796-5111 |
News Archive
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and Tarrot Laboratories, a business unit of Cedars-Sinai Medical Center, today announced the execution of an exclusive research collaboration and license agreement. The collaboration will focus on identifying genetic or serologic markers associated with clinical responses to anti-TNF therapies such as Cimzia, Humira and Remicade utilized in the treatment of Crohn's Disease, and the subsequent development of diagnostic tests.
Government health experts recommended Friday that all children be tested for high cholesterol before they reach puberty, in an effort to get an early start in preventing cardiovascular disease. The National Heart, Lung and Blood Institute said a child's first cholesterol check should occur between ages 9 and 11 and the test should be repeated between ages 17 and 21. The American Academy of Pediatrics endorsed the guideline.
Results from a US study suggest there is dysfunction in the neural networks responsible for emotion regulation among patients with bipolar I disorder, even during periods of euthymia.
Safeguard Scientifics, Inc. (NYSE:SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that its annual meeting of shareholders, to be held on Friday, August 28, 2009 at 8 a.m. EDT at Dolce Valley Forge, King of Prussia, PA, will be webcast live and available via toll-free conference call.
› Verified 1 days ago